China Merchants Securities published a bullish note on Apeloa Pharmaceutical (000739.SZ), highlighting its CDMO business as the main profit driver with record-high backlog and new molecule wins.
Apeloa's CDMO momentum and record backlog position it for strong growth, making it a compelling China healthcare play.
Free preview — more China A-share & HK research · About Us · Legal & Privacy